119 related articles for article (PubMed ID: 10202116)
1. Prostaglandins mediate suppression of lymphocyte proliferation and cytokine synthesis in acute Trypanosoma cruzi infection.
Pinge-Filho P; Tadokoro CE; Abrahamsohn IA
Cell Immunol; 1999 Apr; 193(1):90-8. PubMed ID: 10202116
[TBL] [Abstract][Full Text] [Related]
2. Suppressor macrophages in African trypanosomiasis inhibit T cell proliferative responses by nitric oxide and prostaglandins.
Schleifer KW; Mansfield JM
J Immunol; 1993 Nov; 151(10):5492-503. PubMed ID: 8228241
[TBL] [Abstract][Full Text] [Related]
3. Cytokine and nitric oxide regulation of the immunosuppression in Trypanosoma cruzi infection.
Abrahamsohn IA; Coffman RL
J Immunol; 1995 Oct; 155(8):3955-63. PubMed ID: 7561103
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-12 stimulation of lymphoproliferative responses in Trypanosoma cruzi infection.
Galvão da Silva AP; de Almeida Abrahamsohn I
Immunology; 2001 Nov; 104(3):349-54. PubMed ID: 11722650
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin and nitric oxide regulate TNF-alpha production during Trypanosoma cruzi infection.
Borges MM; Kloetzel JK; Andrade HF; Tadokoro CE; Pinge-Filho P; Abrahamsohn I
Immunol Lett; 1998 Aug; 63(1):1-8. PubMed ID: 9719432
[TBL] [Abstract][Full Text] [Related]
6. Differential control of IFN-gamma and IL-2 production during Trypanosoma cruzi infection.
Nabors GS; Tarleton RL
J Immunol; 1991 May; 146(10):3591-8. PubMed ID: 1902857
[TBL] [Abstract][Full Text] [Related]
7. Kinetic analysis of antigen-specific immune responses in resistant and susceptible mice during infection with Trypanosoma cruzi.
Hoft DF; Lynch RG; Kirchhoff LV
J Immunol; 1993 Dec; 151(12):7038-47. PubMed ID: 8258708
[TBL] [Abstract][Full Text] [Related]
8. Characterization of cytokine production in murine Trypanosoma cruzi infection by in situ immunocytochemistry: lack of association between susceptibility and type 2 cytokine production.
Zhang L; Tarleton RL
Eur J Immunol; 1996 Jan; 26(1):102-9. PubMed ID: 8566051
[TBL] [Abstract][Full Text] [Related]
9. Antigen-specific Il-4- and IL-10-secreting CD4+ lymphocytes increase in vivo susceptibility to Trypanosoma cruzi infection.
Barbosa de Oliveira LC; Curotto de Lafaille MA; Collet de Araujo Lima GM; de Almeida Abrahamsohn I
Cell Immunol; 1996 May; 170(1):41-53. PubMed ID: 8660798
[TBL] [Abstract][Full Text] [Related]
10. Resistant mice lacking interleukin-12 become susceptible to Trypanosoma cruzi infection but fail to mount a T helper type 2 response.
Galvão Da Silva AP; Jacysyn JF; De Almeida Abrahamsohn I
Immunology; 2003 Feb; 108(2):230-7. PubMed ID: 12562332
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide-induced apoptotic cell death in the acute phase of Trypanosoma cruzi infection in mice.
Martins GA; Cardoso MA; Aliberti JC; Silva JS
Immunol Lett; 1998 Sep; 63(2):113-20. PubMed ID: 9761373
[TBL] [Abstract][Full Text] [Related]
12. Immunosuppression during acute Trypanosoma cruzi infection: involvement of Ly6G (Gr1(+))CD11b(+ )immature myeloid suppressor cells.
Goñi O; Alcaide P; Fresno M
Int Immunol; 2002 Oct; 14(10):1125-34. PubMed ID: 12356678
[TBL] [Abstract][Full Text] [Related]
13. Synergism between tumor necrosis factor-alpha and interferon-gamma on macrophage activation for the killing of intracellular Trypanosoma cruzi through a nitric oxide-dependent mechanism.
Muñoz-Fernández MA; Fernández MA; Fresno M
Eur J Immunol; 1992 Feb; 22(2):301-7. PubMed ID: 1537373
[TBL] [Abstract][Full Text] [Related]
14. Role of macrophage-derived nitric oxide in suppression of lymphocyte proliferation during blood-stage malaria.
Ahvazi BC; Jacobs P; Stevenson MM
J Leukoc Biol; 1995 Jul; 58(1):23-31. PubMed ID: 7542305
[TBL] [Abstract][Full Text] [Related]
15. Trypanosoma cruzi: IL-10, TNF, IFN-gamma, and IL-12 regulate innate and acquired immunity to infection.
Abrahamsohn IA; Coffman RL
Exp Parasitol; 1996 Nov; 84(2):231-44. PubMed ID: 8932773
[TBL] [Abstract][Full Text] [Related]
16. Impaired production of proinflammatory cytokines and host resistance to acute infection with Trypanosoma cruzi in mice lacking functional myeloid differentiation factor 88.
Campos MA; Closel M; Valente EP; Cardoso JE; Akira S; Alvarez-Leite JI; Ropert C; Gazzinelli RT
J Immunol; 2004 Feb; 172(3):1711-8. PubMed ID: 14734753
[TBL] [Abstract][Full Text] [Related]
17. Benznidazole, a drug employed in the treatment of Chagas' disease, down-regulates the synthesis of nitrite and cytokines by murine stimulated macrophages.
Revelli S; Le Page C; Piaggio E; Wietzerbin J; Bottasso O
Clin Exp Immunol; 1999 Nov; 118(2):271-7. PubMed ID: 10540190
[TBL] [Abstract][Full Text] [Related]
18. Acute Trypanosoma cruzi infection: IL-12, IL-18, TNF, sTNFR and NO in T. rangeli-vaccinated mice.
Basso B; Cervetta L; Moretti E; Carlier Y; Truyens C
Vaccine; 2004 May; 22(15-16):1868-72. PubMed ID: 15121297
[TBL] [Abstract][Full Text] [Related]
19. Macrophage migration inhibitory factor contributes to host defense against acute Trypanosoma cruzi infection.
Reyes JL; Terrazas LI; Espinoza B; Cruz-Robles D; Soto V; Rivera-Montoya I; Gómez-García L; Snider H; Satoskar AR; Rodríguez-Sosa M
Infect Immun; 2006 Jun; 74(6):3170-9. PubMed ID: 16714544
[TBL] [Abstract][Full Text] [Related]
20. Type I IFNs stimulate nitric oxide production and resistance to Trypanosoma cruzi infection.
Costa VM; Torres KC; Mendonça RZ; Gresser I; Gollob KJ; Abrahamsohn IA
J Immunol; 2006 Sep; 177(5):3193-200. PubMed ID: 16920958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
